Autologous and allogenic natural cell mediated cytotoxicity at the single cell level: divergent effects of interferons and interleukin 2 on binding and lysis
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 47 (1-2) , 69-77
- https://doi.org/10.1016/0304-3835(89)90179-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Current Understanding of the Lymphokine-Activated Killer Cell PhenomenonPublished by S. Karger AG ,1987
- Therapeutic Potential of Cytokines: A Comparison of Preclinical and Clinical StudiesPublished by S. Karger AG ,1987
- Human interferon-gamma increases adhesion of cultured carcinoma cells to the substratumCancer Letters, 1987
- Lymphokine-activated killer cells. Analysis of progenitors and effectors.The Journal of Experimental Medicine, 1986
- A Biological Approach to Optimize Interferon Treatment in Hairy Cell LeukemiaImmunobiology, 1986
- Regulation of Natural Killer Cytotoxicity by Escherichia coli‐Derived Human Interferon GammaScandinavian Journal of Immunology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Inhibition of cell proliferation by interferonsEuropean Journal of Biochemistry, 1984